Home > Cashflow Statement > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹915 Cr₹997 Cr₹364 Cr₹791 Cr₹605 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Operating Activities ratio of GLAND PHARMA is ₹915 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹915 Cr
Mar2024₹997 Cr
Mar2023₹364 Cr
Mar2022₹791 Cr
Mar2021₹605 Cr

How is Cash Flow from Operating Activities of GLAND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹915 Cr
-8.23
Mar2024 ₹997 Cr
173.87
Mar2023 ₹364 Cr
-53.97
Mar2022 ₹791 Cr
30.72
Mar2021 ₹605 Cr -

Compare Cash Flow from Operating Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,521.8 Cr -2.4% 8.4% 21% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.4%

8.4%

21%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses